Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What market expansion outlook does the Tumor Ablation Therapy Devices Market show for the 2026–2030 period?
The tumor ablation therapy devices market size has seen swift expansion in recent years. It is anticipated to expand from $0.82 billion in 2025 to $0.95 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.0%. The historical growth of this market is attributable to a rise in cancer incidence rates, an increase in oncology treatment centers, the growing acceptance of minimally invasive therapies, the availability of sophisticated imaging technologies, and an increasing preference for treatments that preserve organs.
The tumor ablation therapy devices market is anticipated to experience substantial expansion over the next few years, with its size projected to reach $1.61 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 14.2%. This growth in the upcoming period is largely driven by increased investments in precision oncology, a rising demand for outpatient cancer treatments, the advancement of sophisticated ablation technologies, greater integration of imaging and therapy systems, and an intensifying focus on personalized cancer care. Prominent trends for the forecast period encompass a growing adoption of minimally invasive tumor ablation procedures, an increasing reliance on image-guided ablation systems, an expanding need for organ-specific ablation technologies, the broader application of percutaneous treatment approaches, and an elevated emphasis on precision oncology.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3351&type=smp
What Drivers Are Shaping The Development Of The Tumor Ablation Therapy Devices Market?
The escalating incidence of cancer represents a primary factor fueling the growth of the tumor ablation therapy devices market. Cancer is recognized as the second leading cause of death globally, with roughly 1 in 6 deaths attributed to it worldwide. The increasing prevalence of cancer is primarily driven by an aging demographic, as older individuals inherently face a higher likelihood of developing various cancer types during their lifetime. Tumor ablation is a minimally invasive medical procedure widely employed in the treatment of tumors affecting the lung, liver, kidney, and bone. For example, in 2023, the American Cancer Society Inc., a US-based non-profit health group, anticipated 1,958,310 new cancer cases to be diagnosed in the US, an uptick compared to the more than 1,918,030 new cancer cases recorded in 2022. This procedure offers an effective solution for patients for whom chemotherapy or radiotherapy has been unsuccessful, thus supporting the expansion of the tumor ablation therapy devices market.
Which Segments Are Contributing To The Growth Of The Tumor Ablation Therapy Devices Market?
The tumor ablation therapy devices market covered in this report is segmented –
1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
2) By Treatment: Surgical, Laparoscopic, Percutaneous
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Oncology Clinics, Other End Users
Subsegments:
1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices, Bipolar RFA Devices
2) By Microwave Ablation: High-frequency Microwave Devices, Low-frequency Microwave Devices
3) By Cryoablation: Liquid Nitrogen-based Devices, Argon Gas-based Devices
4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems, High-voltage Pulse Generators
5) By Other Technologies: Laser Ablation Devices, Ultrasound-guided High-intensity Focused Ultrasound (HIFU), Chemical Ablation Techniques
Which Trends Are Influencing The Performance And Direction Of The Tumor Ablation Therapy Devices Market?
Leading companies in the tumor ablation therapy devices market are prioritizing the creation of minimally invasive treatments to secure a competitive advantage. These minimally invasive therapies are employed for tumor ablation, providing accurate and efficient treatment with reduced impact on nearby tissues. For example, in August 2023, Francis Medical Inc., a US-based provider of minimally invasive treatment solutions for prostate, kidney, and bladder cancer, had its Vanquish minimally invasive water vapor ablation therapy granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This approval is intended to accelerate the device’s development and streamline its regulatory evaluation, potentially enabling faster patient access. Vanquish operates by using the thermal energy from a small quantity of sterile water to deliver precise treatments to cancerous tissue via a simple transurethral procedure. The treatment is engineered to eliminate cancer cells while safeguarding adjacent structures, thereby lessening the risk of severe side effects often associated with other prostate cancer therapies.
Who Are The Major Companies Operating In The Tumor Ablation Therapy Devices Market?
Major companies operating in the tumor ablation therapy devices market are Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, Theraclion, INTIO Inc., Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Bovie Medical Corporation,
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Tumor Ablation Therapy Devices Market?
North America was the largest region in the tumor ablation therapy devices market in 2025. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Tumor Ablation Therapy Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3351&type=smp
Browse Through More Reports Similar to the Global Tumor Ablation Therapy Devices Market 2026, By The Business Research Company
Tumor Ablation Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report
Oncology Ablation Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report
Ablation Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ablation-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company